StockTipsArenaBeta

BUY Gland Pharma Limited — Ansh Jogendra Bhilwar

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: NA (inferred 1 year)11 Aug 2026via Zee Business (Live)

Entry₹2,845.5Inferred
Target₹3,000
Total upside +5.43% (call closed)
Stop loss₹2,515-11.61% risk
Exit₹3,00014 Aug 2026, 12:08 pm
Target hit+5.43%0.00%upside left
Follow Ansh Jogendra Bhilwar for new callsGet alertsWatch GLAND for new buy/sell callsGet alertsSee 7 active Long-term calls on GLANDSee 148 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 14 Aug 2026
14 supporting6 neutral3 opposing
Supports the BUY call (14)

Gland Pharma appoints Dr. Reddy’s Deepak Sapra as CEO; stock hits 52-week high

NewsCnbc-Tv18·14 Aug · today

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·12 Aug · 2d ago

Gland Pharma reported Q1FY27 financial results, showing a 20% year-on-year revenue growth and a 47% year-on-year PAT growth. The company highlighted strong performance driven by its CDMO strategy and

BSE · Company Update·10 Aug · 3d ago

(opens in new tab)

Gland Pharma shares jump 12% to 52-week high; Here's a bull and bear case scenario after Q1 results

NewsCnbc-Tv18·11 Aug · 3d ago

(opens in new tab)

Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?

NewsEt-Markets·11 Aug · 3d ago

(opens in new tab)
Neutral / worth noting (6)

Gland Pharma Ltd has appointed Mr. Deepak Sapra as the new Chief Executive Officer (CEO) of the company, effective November 16, 2026. Mr. Sapra has 27 years of experience in the pharmaceutical industr

BSE · Company Update·14 Aug · today

(opens in new tab)

Mr Deepak Sapra appointed as Chief Executive Officer of the company effective November 16, 2026.

NSE · Appointment·14 Aug · today

(opens in new tab)

Gland Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·10 Aug · 3d ago

(opens in new tab)

Gland Pharma to Triveni Turbines: Top stocks to track in trade today

NewsCnbc-Tv18·11 Aug · 3d ago

(opens in new tab)
Weighs against the BUY call (3)

2 other SEBI-registered advisors have active long-term SELL calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·12 Aug · 2d ago

Q1 Results Today Highlights: Bharat Forge shares tank after Q1 loss, Kwality Pharma, Ramco Industries Q1 PAT up, Hindustan Copper PAT down q-o-q, AstraZeneca, Info Edge & Astra Microwave profit dip, Vi, Bosch, Lloyds Metals, Gland Pharma, Zee Entertainment, KEC International to announce Q1 results

NewsHbl·10 Aug · 3d ago

(opens in new tab)

Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan

NewsNdtv-Profit·22 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Ansh Jogendra Bhilwar

Every call and its outcome